Approaches for discovering novel bioactive small molecules targeting autophagy

References

• Rubinsztein DC, Codogno P, Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov. 2012;11(9):709–730.
   PubMed Web of Science ®Google Scholar
• Benjamin D, Colombi M, Moroni C, et al. Rapamycin passes the torch: a new generation of mTOR inhibitors. Nat Rev Drug Discov. 2011;10(11):868–880.
   PubMed Web of Science ®Google Scholar
• Gibbons JJ, Abraham RT, Yu K. Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth. Semin Oncol. 2009;36 Suppl 3:S3–S17.
   PubMedGoogle Scholar
• Kapuy O, Vinod PK, Banhegyi G. mTOR inhibition increases cell viability via autophagy induction during endoplasmic reticulum stress - an experimental and modeling study. FEBS Open Bio. 2014;4:704–713.
   PubMed Web of Science ®Google Scholar
• Mori S, Nada S, Kimura H, et al. The mTOR pathway controls cell proliferation by regulating the FoxO3a transcription factor via SGK1 kinase. PLoS One. 2014;9(2):e88891.
   PubMed Web of Science ®Google Scholar
• Fingar DC, Richardson CJ, Tee AR, et al. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol Cell Biol. 2004;24(1):200–216.
   PubMed Web of Science ®Google Scholar
• Shimobayashi M, Hall MN. Making new contacts: the mTOR network in metabolism and signalling crosstalk. Nat Rev Mol Cell Biol. 2014;15(3):155–162.
   PubMed Web of Science ®Google Scholar
• Wang X, Proud CG. The mTOR pathway in the control of protein synthesis. Physiology (Bethesda). 2006;21:362–369.
   PubMed Web of Science ®Google Scholar
• You JS, Anderson GB, Dooley MS, et al. The role of mTOR signaling in the regulation of protein synthesis and muscle mass during immobilization in mice. Dis Model Mech. 2015;8(9):1059–1069.
   PubMed Web of Science ®Google Scholar
• Atala A. Re: a unifying model for mTORC1-mediated regulation of mRNA translation. J Urol. 2012;188(6):2433–2434.
   PubMed Web of Science ®Google Scholar
• Powell JD, Pollizzi KN, Heikamp EB, et al. Regulation of immune responses by mTOR. Annu Rev Immunol. 2012;30:39–68.
   PubMed Web of Science ®Google Scholar
• Weichhart T, Hengstschlager M, Linke M. Regulation of innate immune cell function by mTOR. Nat Rev Immunol. 2015;15(10):599–614.
   PubMed Web of Science ®Google Scholar
• Karar J, Maity A. PI3K/AKT/mTOR pathway in angiogenesis. Front Mol Neurosci. 2011;4:51.
   PubMed Web of Science ®Google Scholar
• Vezina C, Kudelski A, Sehgal SN. Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J Antibiot (Tokyo). 1975;28(10):721–726.
   PubMed Web of Science ®Google Scholar
• Martel RR, Klicius J, Galet S. Inhibition of the immune response by rapamycin, a new antifungal antibiotic. Can J Physiol Pharmacol. 1977;55(1):48–51.
   PubMed Web of Science ®Google Scholar
• Dumont FJ, Su Q. Mechanism of action of the immunosuppressant rapamycin. Life Sci. 1996;58(5):373–395.
   PubMed Web of Science ®Google Scholar
• Yan ZC, Bai YJ, Tian Z, et al. Anti-proliferation effects of Sirolimus sustained delivery film in rabbit glaucoma filtration surgery. Mol Vis. 2011;17:2495–2506.
   PubMed Web of Science ®Google Scholar
• Heitman J, Movva NR, Hall MN. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science. 1991;253(5022):905–909.
   PubMed Web of Science ®Google Scholar
• Strimpakos AS, Karapanagiotou EM, Saif MW, et al. The role of mTOR in the management of solid tumors: an overview. Cancer Treat Rev. 2009;35(2):148–159.
   PubMed Web of Science ®Google Scholar
• Malik SA, Orhon I, Morselli E, et al. BH3 mimetics activate multiple pro-autophagic pathways. Oncogene. 2011;30(37):3918–3929.
   PubMed Web of Science ®Google Scholar
• Vicencio JM, Ortiz C, Criollo A, et al. The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1. Cell Death Differ. 2009;16(7):1006–1017.
   PubMed Web of Science ®Google Scholar
• Dai JP, Zhao XF, Zeng J, et al. Drug screening for autophagy inhibitors based on the dissociation of Beclin1-Bcl2 complex using BiFC technique and mechanism of eugenol on anti-influenza A virus activity. PLoS One. 2013;8(4):e61026.
   PubMed Web of Science ®Google Scholar
• Cho YS, Yen CN, Shim JS, et al. Antidepressant indatraline induces autophagy and inhibits restenosis via suppression of mTOR/S6 kinase signaling pathway. Sci Rep. 2016;6:34655.
   PubMed Web of Science ®Google Scholar
• Dai JP, Li WZ, Zhao XF, et al. A drug screening method based on the autophagy pathway and studies of the mechanism of evodiamine against influenza A virus. PLoS One. 2012;7(8):e42706.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Seglen PO. The Norse god of autophagy. Interviewed by Daniel J Klionsky. Autophagy. 2010;6(8):1017–1031.
   PubMed Web of Science ®Google Scholar
• Cho YS, Kwon HJ. Control of autophagy with small molecules. Arch Pharm Res. 2010;33(12):1881–1889.
   PubMed Web of Science ®Google Scholar
• Nath S, Dancourt J, Shteyn V, et al. Lipidation of the LC3/GABARAP family of autophagy proteins relies on a membrane-curvature-sensing domain in Atg3. Nat Cell Biol. 2014;16(5):415–424.
   PubMed Web of Science ®Google Scholar
• Kabeya Y, Mizushima N, Yamamoto A, et al. LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J Cell Sci. 2004;117(Pt 13):2805–2812.
   PubMed Web of Science ®Google Scholar
• Nakatogawa H, Ichimura Y, Ohsumi Y. Atg8, a ubiquitin-like protein required for autophagosome formation, mediates membrane tethering and hemifusion. Cell. 2007;130(1):165–178.
   PubMed Web of Science ®Google Scholar
• Jiang P, Mizushima N. LC3- and p62-based biochemical methods for the analysis of autophagy progression in mammalian cells. Methods. 2015;75:13–18.
   PubMed Web of Science ®Google Scholar
• Cha-Molstad H, Kwon YT, Kim BY. Amino-terminal arginylation as a degradation signal for selective autophagy. BMB Rep. 2015;48(9):487–488.
   PubMed Web of Science ®Google Scholar
• Tong Y, Song F. Intracellular calcium signaling regulates autophagy via calcineurin-mediated TFEB dephosphorylation. Autophagy. 2015;11(7):1192–1195.
   PubMed Web of Science ®Google Scholar
• Settembre C, Di Malta C, Polito VA, et al. TFEB links autophagy to lysosomal biogenesis. Science. 2011;332(6036):1429–1433.
   PubMed Web of Science ®Google Scholar
• Zoncu R, Bar-Peled L, Efeyan A, et al. mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science. 2011;334(6056):678–683.
   PubMed Web of Science ®Google Scholar
• Settembre C, Zoncu R, Medina DL, et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. Embo J. 2012;31(5):1095–1108.
   PubMed Web of Science ®Google Scholar
• Russell RC, Yuan HX, Guan KL. Autophagy regulation by nutrient signaling. Cell Res. 2014;24(1):42–57.
   PubMed Web of Science ®Google Scholar
• Filomeni G, De Zio D, Cecconi F. Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death Differ. 2015;22(3):377–388.
   PubMed Web of Science ®Google Scholar
• Poillet-Perez L, Despouy G, Delage-Mourroux R, et al. Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy. Redox Biol. 2015;4:184–192.
   PubMed Web of Science ®Google Scholar
• Grose C. Autophagy during common bacterial and viral infections of children. Pediatr Infect Dis J. 2010;29(11):1040–1042.
   PubMed Web of Science ®Google Scholar
• Wileman T. Autophagy as a defence against intracellular pathogens. Essays Biochem. 2013;55:153–163.
   PubMed Web of Science ®Google Scholar
• Singh R, Kaushik S, Wang Y, et al. Autophagy regulates lipid metabolism. Nature. 2009;458(7242):1131–1135.
   PubMed Web of Science ®Google Scholar
• Rubinsztein DC, Marino G, Kroemer G. Autophagy and aging. Cell. 2011;146(5):682–695.
   PubMed Web of Science ®Google Scholar
• Li X, Xu HL, Liu YX, et al. Autophagy modulation as a target for anticancer drug discovery. Acta Pharmacol Sin. 2013;34(5):612–624.
   PubMed Web of Science ®Google Scholar
• White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer. 2012;12(6):401–410.
   PubMed Web of Science ®Google Scholar
• Liang XH, Jackson S, Seaman M, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 1999;402(6762):672–676.
   PubMed Web of Science ®Google Scholar
• Kang MR, Kim MS, Oh JE, et al. Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability. J Pathol. 2009;217(5):702–706.
   PubMed Web of Science ®Google Scholar
• Kim JH, Song HK. Swapping of interaction partners with ATG5 for autophagosome maturation. BMB Rep. 2015;48(3):129–130.
   PubMed Web of Science ®Google Scholar
• Yang ZJ, Chee CE, Huang S, et al. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther. 2011;10(9):1533–1541.
   PubMed Web of Science ®Google Scholar
• Rabinowitz JD, White E. Autophagy and metabolism. Science. 2010;330(6009):1344–1348.
   PubMed Web of Science ®Google Scholar
• Yang L, Li P, Fu S, et al. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab. 2010;11(6):467–478.
   PubMed Web of Science ®Google Scholar
• Hara T, Nakamura K, Matsui M, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006;441(7095):885–889.
   PubMed Web of Science ®Google Scholar
• Tian T, Huang C, Tong J, et al. TDP-43 potentiates alpha-synuclein toxicity to dopaminergic neurons in transgenic mice. Int J Biol Sci. 2011;7(2):234–243.
   PubMed Web of Science ®Google Scholar
• Ryan BJ, Hoek S, Fon EA, et al. Mitochondrial dysfunction and mitophagy in Parkinson’s: from familial to sporadic disease. Trends Biochem Sci. 2015;40(4):200–210.
   PubMed Web of Science ®Google Scholar
• Murphy MP, LeVine H 3rd. Alzheimer’s disease and the amyloid-beta peptide. J Alzheimers Dis. 2010;19(1):311–323.
   PubMed Web of Science ®Google Scholar
• Zhao T, Hong Y, Li XJ, et al. Subcellular clearance and accumulation of Huntington disease protein: a mini-review. Front Mol Neurosci. 2016;9:27.
   PubMed Web of Science ®Google Scholar
• Pickrell AM, Youle RJ. The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson’s disease. Neuron. 2015;85(2):257–273.
   PubMed Web of Science ®Google Scholar
• Jones R. The roles of PINK1 and Parkin in Parkinson’s disease. PLoS Biol. 2010;8(1):e1000299.
   PubMedGoogle Scholar
• Imai Y, Lu B. Mitochondrial dynamics and mitophagy in Parkinson’s disease: disordered cellular power plant becomes a big deal in a major movement disorder. Curr Opin Neurobiol. 2011;21(6):935–941.
   PubMed Web of Science ®Google Scholar
• Yuk JM, Yoshimori T, Jo EK. Autophagy and bacterial infectious diseases. Exp Mol Med. 2012;44(2):99–108.
   PubMed Web of Science ®Google Scholar
• Alexander DE, Leib DA. Xenophagy in herpes simplex virus replication and pathogenesis. Autophagy. 2008;4(1):101–103.
   PubMed Web of Science ®Google Scholar
• Choy A, Roy CR. Autophagy and bacterial infection: an evolving arms race. Trends Microbiol. 2013;21(9):451–456.
   PubMed Web of Science ®Google Scholar
• Nakagawa I, Amano A, Mizushima N, et al. Autophagy defends cells against invading group A Streptococcus. Science. 2004;306(5698):1037–1040.
   PubMed Web of Science ®Google Scholar
• Williams A, Sarkar S, Cuddon P, et al. Novel targets for Huntington’s disease in an mTOR-independent autophagy pathway. Nat Chem Biol. 2008;4(5):295–305.
   PubMed Web of Science ®Google Scholar
• Oh M, Choi IK, Kwon HJ. Inhibition of histone deacetylase1 induces autophagy. Biochem Biophys Res Commun. 2008;369(4):1179–1183.
   PubMed Web of Science ®Google Scholar
• Verschooten L, Barrette K, Van Kelst S, et al. Autophagy inhibitor chloroquine enhanced the cell death inducing effect of the flavonoid luteolin in metastatic squamous cell carcinoma cells. PLoS One. 2012;7(10):e48264.
   PubMed Web of Science ®Google Scholar
• Simioni C, Cani A, Martelli AM, et al. Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation. Oncotarget. 2014;5(20):10034–10047.
   PubMed Web of Science ®Google Scholar
• Li M, Khambu B, Zhang H, et al. Suppression of lysosome function induces autophagy via a feedback down-regulation of MTOR complex 1 (MTORC1) activity. J Biol Chem. 2013;288(50):35769–35780.
   PubMed Web of Science ®Google Scholar
• Hsin IL, Sheu GT, Jan MS, et al. Inhibition of lysosome degradation on autophagosome formation and responses to GMI, an immunomodulatory protein from Ganoderma microsporum. Br J Pharmacol. 2012;167(6):1287–1300.
   PubMed Web of Science ®Google Scholar
• Crazzolara R, Bradstock KF, Bendall LJ. RAD001 (Everolimus) induces autophagy in acute lymphoblastic leukemia. Autophagy. 2009;5(5):727–728.
   PubMed Web of Science ®Google Scholar
• Jung M, Lee J, Seo HY, et al. Cathepsin inhibition-induced lysosomal dysfunction enhances pancreatic beta-cell apoptosis in high glucose. PLoS One. 2015;10(1):e0116972.
   PubMed Web of Science ®Google Scholar
• Park D, Jeong H, Lee MN, et al. Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition. Sci Rep. 2016;6:21772.
   PubMed Web of Science ®Google Scholar
• Jung CH, Ro SH, Cao J, et al. mTOR regulation of autophagy. FEBS Lett. 2010;584(7):1287–1295.
   PubMed Web of Science ®Google Scholar
• Kim D, Hwang HY, Kim JY, et al. FK506, an immunosuppressive drug, induces autophagy by binding to the V-ATPase catalytic subunit A in neuronal cells. J Proteome Res. 2017;16(1):55–64.
   PubMed Web of Science ®Google Scholar
• Xie Z, Xie Y, Xu Y, et al. Bafilomycin A1 inhibits autophagy and induces apoptosis in MG63 osteosarcoma cells. Mol Med Rep. 2014;10(2):1103–1107.
   PubMed Web of Science ®Google Scholar
• Kochl R, Hu XW, Chan EY, et al. Microtubules facilitate autophagosome formation and fusion of autophagosomes with endosomes. Traffic. 2006;7(2):129–145.
   PubMed Web of Science ®Google Scholar
• Palmeira dos Santos C, Pereira GJ, Barbosa CM, et al. Comparative study of autophagy inhibition by 3MA and CQ on Cytarabineinduced death of leukaemia cells. J Cancer Res Clin Oncol. 2014;140(6):909–920.
   PubMed Web of Science ®Google Scholar
• Guo S, Long M, Li X, et al. Curcumin activates autophagy and attenuates oxidative damage in EA.hy926 cells via the Akt/mTOR pathway. Mol Med Rep. 2016;13(3):2187–2193.
   PubMed Web of Science ®Google Scholar
• Huang WW, Tsai SC, Peng SF, et al. Kaempferol induces autophagy through AMPK and AKT signaling molecules and causes G2/M arrest via downregulation of CDK1/cyclin B in SK-HEP-1 human hepatic cancer cells. Int J Oncol. 2013;42(6):2069–2077.
   PubMed Web of Science ®Google Scholar
• The LM. Success of natural products in drug discovery. Pharmacol Pharm. 2013;04(03):17–31.
   Google Scholar
• Harvey AL. Natural products in drug discovery. Drug Discov Today. 2008;13(19–20):894–901.
   PubMed Web of Science ®Google Scholar
• Vingtdeux V, Chandakkar P, Zhao H, et al. Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-beta peptide degradation. FASEB J. 2011;25(1):219–231.
   PubMed Web of Science ®Google Scholar
• Busschaert N, Kirby IL, Young S, et al. Squaramides as potent transmembrane anion transporters. Angew Chem Int Ed Engl. 2012;51(18):4426–4430.
   PubMed Web of Science ®Google Scholar
• Yoshioka M, Yamada K, Tanaka T, et al. The fungicidal activity of amphotericin B requires autophagy-dependent targeting to the vacuole under a nutrient-starved condition in Saccharomyces cerevisiae. Microbiology. 2016;162:848–854.
   PubMed Web of Science ®Google Scholar
• Hack N, Carey F, Crawford N. The inhibition of platelet cyclo-oxygenase by aspirin is associated with the acetylation of a 72kDa polypeptide in the intracellular membranes. Biochem J. 1984;223(1):105–111.
   PubMed Web of Science ®Google Scholar
• Din FV, Valanciute A, Houde VP, et al. Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells. Gastroenterology. 2012;142(7):1504–15e3.
   PubMed Web of Science ®Google Scholar
• Egan DF, Shackelford DB, Mihaylova MM, et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science. 2011;331(6016):456–461.
   PubMed Web of Science ®Google Scholar
• Kim J, Kundu M, Viollet B, et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13(2):132–141.
   PubMed Web of Science ®Google Scholar
• Wassermann AM, Lounkine E, Hoepfner D, et al. Dark chemical matter as a promising starting point for drug lead discovery. Nat Chem Biol. 2015;11(12):958–966.
   PubMed Web of Science ®Google Scholar
• Hundeshagen P, Hamacher-Brady A, Eils R, et al. Concurrent detection of autolysosome formation and lysosomal degradation by flow cytometry in a high-content screen for inducers of autophagy. BMC Biol. 2011;9:38.
   PubMed Web of Science ®Google Scholar
• Balgi AD, Fonseca BD, Donohue E, et al. Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling. PLoS One. 2009;4(9):e7124.
   PubMed Web of Science ®Google Scholar
• Bauer PO, Wong HK, Oyama F, et al. Inhibition of Rho kinases enhances the degradation of mutant Huntingtin. J Biol Chem. 2009;284(19):13153–13164.
   PubMed Web of Science ®Google Scholar
• Schiebler M, Brown K, Hegyi K, et al. Functional drug screening reveals anticonvulsants as enhancers of mTOR-independent autophagic killing of mycobacterium tuberculosis through inositol depletion. EMBO Mol Med. 2015;7(2):127–139.
   PubMed Web of Science ®Google Scholar
• Goodall ML, Wang T, Martin KR, et al. Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenib. Autophagy. 2014;10(6):1120–1136.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Malerva L, Park J, Zou L, et al. High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy. Proc Natl Acad Sci U S A. 2011;108(5):2058–2063.
   PubMed Web of Science ®Google Scholar
• Kuo SY, Castoreno AB, Aldrich LN, et al. Small-molecule enhancers of autophagy modulate cellular disease phenotypes suggested by human genetics. Proc Natl Acad Sci U S A. 2015;112(31):E4281–E4287.
   PubMed Web of Science ®Google Scholar
• Grozinger CM, Chao ED, Blackwell HE, et al. Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening. J Biol Chem. 2001;276(42):38837–38843.
   PubMed Web of Science ®Google Scholar
• Kazantsev AG, Thompson LM. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat Rev Drug Discov. 2008;7(10):854–868.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yu J, Pan H, et al. Small molecule regulators of autophagy identified by an image-based high-throughput screen. Proc Natl Acad Sci U S A. 2007;104(48):19023–19028.
   PubMed Web of Science ®Google Scholar
• Renna M, Jimenez-Sanchez M, Sarkar S, et al. Chemical inducers of autophagy that enhance the clearance of mutant proteins in neurodegenerative diseases. J Biol Chem. 2010;285(15):11061–11067.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Perlstein EO, Imarisio S, et al. Small molecules enhance autophagy and reduce toxicity in Huntington’s disease models. Nat Chem Biol. 2007;3(6):331–338.
   PubMed Web of Science ®Google Scholar
• Liu S, Zhu L, Zhang J, et al. Anti-osteoclastogenic activity of isoliquiritigenin via inhibition of NF-kappaB-dependent autophagic pathway. Biochem Pharmacol. 2016;106:82–93.
   PubMed Web of Science ®Google Scholar
• Chauhan S, Ahmed Z, Bradfute SB, et al. Pharmaceutical screen identifies novel target processes for activation of autophagy with a broad translational potential. Nat Commun. 2015;6:8620.
   PubMed Web of Science ®Google Scholar
• Groth-Pedersen L, Ostenfeld MS, Hoyer-Hansen M, et al. Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome-destabilizing siramesine. Cancer Res. 2007;67(5):2217–2225.
   PubMed Web of Science ®Google Scholar
• Kim DS, Li B, Rhew KY, et al. The regulatory mechanism of 4-phenylbutyric acid against ER stress-induced autophagy in human gingival fibroblasts. Arch Pharm Res. 2012;35(7):1269–1278.
   PubMed Web of Science ®Google Scholar
• Jo YK, Park SJ, Shin JH, et al. ARP101, a selective MMP-2 inhibitor, induces autophagy-associated cell death in cancer cells. Biochem Biophys Res Commun. 2011;404(4):1039–1043.
   PubMed Web of Science ®Google Scholar
• Shu CW, Liu PF, Huang CM. High throughput screening for drug discovery of autophagy modulators. Comb Chem High Throughput Screen. 2012;15(9):721–729.
   PubMed Web of Science ®Google Scholar
• Farkas T, Daugaard M, Jaattela M. Identification of small molecule inhibitors of phosphatidylinositol 3-kinase and autophagy. J Biol Chem. 2011;286(45):38904–38912.
   PubMed Web of Science ®Google Scholar
• Xing C, Zhu B, Liu H, et al. Class I phosphatidylinositol 3-kinase inhibitor LY294002 activates autophagy and induces apoptosis through p53 pathway in gastric cancer cell line SGC7901. Acta Biochim Biophys Sin (Shanghai). 2008;40(3):194–201.
   PubMed Web of Science ®Google Scholar
• Deppe J, Popp T, Egea V, et al. Impairment of hypoxia-induced HIF-1alpha signaling in keratinocytes and fibroblasts by sulfur mustard is counteracted by a selective PHD-2 inhibitor. Arch Toxicol. 2016;90(5):1141–1150.
   PubMed Web of Science ®Google Scholar
• Sadaie M, Dillon C, Narita M, et al. Cell-based screen for altered nuclear phenotypes reveals senescence progression in polyploid cells after Aurora kinase B inhibition. Mol Biol Cell. 2015;26(17):2971–2985.
   PubMed Web of Science ®Google Scholar
• Liu LL, Long ZJ, Wang LX, et al. Inhibition of mTOR pathway sensitizes acute myeloid leukemia cells to aurora inhibitors by suppression of glycolytic metabolism. Mol Cancer Res. 2013;11(11):1326–1336.
   PubMed Web of Science ®Google Scholar
• Egan DF, Chun MG, Vamos M, et al. Small molecule inhibition of the autophagy Kinase ULK1 and identification of ULK1 substrates. Mol Cell. 2015;59(2):285–297.
   PubMed Web of Science ®Google Scholar
• Ali D, Hamam R, Alfayez M, et al. Epigenetic library screen identifies abexinostat as novel regulator of adipocytic and osteoblastic differentiation of human skeletal (mesenchymal) stem cells. Stem Cells Transl Med. 2016;5(8):1036–1047.
   PubMed Web of Science ®Google Scholar
• VanderPorten EC, Taverna P, Hogan JN, et al. The Aurora kinase inhibitor SNS-314 shows broad therapeutic potential with chemotherapeutics and synergy with microtubule-targeted agents in a colon carcinoma model. Mol Cancer Ther. 2009;8(4):930–939.
   PubMed Web of Science ®Google Scholar
• Yu K, Toral-Barza L, Shi C, et al. Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin. Cancer Res. 2009;69(15):6232–6240.
   PubMed Web of Science ®Google Scholar
• Iorio F, Isacchi A, Di Bernardo D, et al. Identification of small molecules enhancing autophagic function from drug network analysis. Autophagy. 2010;6(8):1204–1205.
   PubMed Web of Science ®Google Scholar
• Garcia-Martinez JM, Moran J, Clarke RG, et al. Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR). Biochem J. 2009;421(1):29–42.
   PubMed Web of Science ®Google Scholar
• Cordaro M, Paterniti I, Siracusa R, et al. KU0063794, a dual mTORC1 and mTORC2 inhibitor, reduces neural tissue damage and locomotor impairment after spinal cord injury in mice. Mol Neurobiol. 2016;54(4):2415–2427.
   PubMed Web of Science ®Google Scholar
• Yuan CX, Zhou ZW, Yang YX, et al. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells. Drug Des Devel Ther. 2015;9:1293–1318.
   PubMed Web of Science ®Google Scholar
• Li JP, Yang YX, Liu QL, et al. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. Drug Des Devel Ther. 2015;9:1627–1652.
   PubMed Web of Science ®Google Scholar
• Ding YH, Zhou ZW, Ha CF, et al. Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells. Drug Des Devel Ther. 2015;9:425–464.
   PubMed Web of Science ®Google Scholar
• Wager TT, Hou X, Verhoest PR, et al. Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties. ACS Chem Neurosci. 2010;1(6):435–449.
   PubMed Web of Science ®Google Scholar
• Chakrabarti A, Melesina J, Kolbinger FR, et al. Targeting histone deacetylase 8 as a therapeutic approach to cancer and neurodegenerative diseases. Future Med Chem. 2016;8(13):1609–1634.
   PubMed Web of Science ®Google Scholar
• Swinney DC. Phenotypic vs. target-based drug discovery for first-in-class medicines. Clin Pharmacol Ther. 2013;93(4):299–301.
   PubMed Web of Science ®Google Scholar
• Carnero A. High throughput screening in drug discovery. Clin Transl Oncol. 2006;8(7):482–490.
   PubMedGoogle Scholar
• Singh SB, Davis AS, Taylor GA, et al. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science. 2006;313(5792):1438–1441.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdalla FC, Abeliovich H, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012;8(4):445–544.
   PubMed Web of Science ®Google Scholar
• Paglin S, Hollister T, Delohery T, et al. A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res. 2001;61(2):439–444.
   PubMed Web of Science ®Google Scholar
• Larsen KB, Lamark T, Øvervatn A, et al. A reporter cell system to monitor autophagy based on p62/SQSTM1. Autophagy. 2014;6(6):784–793.
   Google Scholar
• Wang Y, Li P, Wang S, et al. Anticancer peptidylarginine deiminase (PAD) inhibitors regulate the autophagy flux and the mammalian target of rapamycin complex 1 activity. J Biol Chem. 2012;287(31):25941–25953.
   PubMed Web of Science ®Google Scholar
• Shimizu S, Takehara T, Hikita H, et al. Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma. Int J Cancer. 2012;131(3):548–557.
   PubMed Web of Science ®Google Scholar
• Dunn WA Jr. Autophagy and related mechanisms of lysosome-mediated protein degradation. Trends Cell Biol. 1994;4(4):139–143.
   PubMedGoogle Scholar
• Yang Y, Janich S, Cohn JA, et al. The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment. Proc Natl Acad Sci U S A. 1993;90(20):9480–9484.
   PubMed Web of Science ®Google Scholar
• Kim YC, Guan KL. mTOR: a pharmacologic target for autophagy regulation. J Clin Invest. 2015;125(1):25–32.
   PubMed Web of Science ®Google Scholar
• Clark SL Jr. Cellular differentiation in the kidneys of newborn mice studies with the electron microscope. J Biophys Biochem Cytol. 1957;3(3):349–362.
   PubMedGoogle Scholar
• Mitchener JS, Shelburne JD, Bradford WD, et al. Cellular autophagocytosis induced by deprivation of serum and amino acids in HeLa cells. Am J Pathol. 1976;83(3):485–492.
   PubMed Web of Science ®Google Scholar
• Xu J, Ji J, Yan XH. Cross-talk between AMPK and mTOR in regulating energy balance. Crit Rev Food Sci Nutr. 2012;52(5):373–381.
   PubMed Web of Science ®Google Scholar
• Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108(8):1167–1174.
   PubMed Web of Science ®Google Scholar
• Ouyang J, Parakhia RA, Ochs RS. Metformin activates AMP kinase through inhibition of AMP deaminase. J Biol Chem. 2011;286(1):1–11.
   PubMed Web of Science ®Google Scholar
• Feng Y, Ke C, Tang Q, et al. Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling. Cell Death Dis. 2014;5:e1088.
   PubMed Web of Science ®Google Scholar
• Kirkegaard T, Roth AG, Petersen NH, et al. Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology. Nature. 2010;463(7280):549–553.
   PubMed Web of Science ®Google Scholar
• Leu JI, Pimkina J, Frank A, et al. A small molecule inhibitor of inducible heat shock protein 70. Mol Cell. 2009;36(1):15–27.
   PubMed Web of Science ®Google Scholar
• Mori M, Hitora T, Nakamura O, et al. Hsp90 inhibitor induces autophagy and apoptosis in osteosarcoma cells. Int J Oncol. 2015;46(1):47–54.
   PubMed Web of Science ®Google Scholar
• Yang YP, Hu LF, Zheng HF, et al. Application and interpretation of current autophagy inhibitors and activators. Acta Pharmacol Sin. 2013;34(5):625–635.
   PubMed Web of Science ®Google Scholar
• Ruan H, Hao S, Young P, et al. Targeting cathepsin B for cancer therapies. Horiz Cancer Res. 2015 2nd Quarter;56:23–40.
   PubMedGoogle Scholar
• Khan O, La Thangue NB. HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications. Immunol Cell Biol. 2012;90(1):85–94.
   PubMed Web of Science ®Google Scholar
• Marks PA, Breslow R. Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug. Nat Biotechnol. 2007;25(1):84–90.
   PubMed Web of Science ®Google Scholar
• Simoes-Pires C, Zwick V, Nurisso A, et al. HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs? Mol Neurodegener. 2013;8:7.
   PubMed Web of Science ®Google Scholar
• Kim Y, Lee J, Ryu H. Modulation of autophagy by miRNAs. BMB Rep. 2015 Jul;48(7):371–372.
   PubMed Web of Science ®Google Scholar
• Frankel LB, Lund AH. MicroRNA regulation of autophagy. Carcinogenesis. 2012;33(11):2018–2025.
   PubMed Web of Science ®Google Scholar
• Frankel LB, Wen J, Lees M, et al. microRNA-101 is a potent inhibitor of autophagy. Embo J. 2011;30(22):4628–4641.
   PubMed Web of Science ®Google Scholar
• Moffat JG, Rudolph J, Bailey D. Phenotypic screening in cancer drug discovery - past, present and future. Nat Rev Drug Discov. 2014;13(8):588–602.
   PubMed Web of Science ®Google Scholar
• Mayr LM, Bojanic D. Novel trends in high-throughput screening. Curr Opin Pharmacol. 2009;9(5):580–588.
   PubMed Web of Science ®Google Scholar
• Soares MA, Lessa JA, Mendes IC, et al. N(4)-Phenyl-substituted 2-acetylpyridine thiosemicarbazones: cytotoxicity against human tumor cells, structure-activity relationship studies and investigation on the mechanism of action. Bioorg Med Chem. 2012;20(11):3396–3409.
   PubMed Web of Science ®Google Scholar
• Chang J, Kim Y, Kwon HJ. Advances in identification and validation of protein targets of natural products without chemical modification. Nat Prod Rep. 2016;33(5):719–730.
   PubMed Web of Science ®Google Scholar
• Wunberg T, Hendrix M, Hillisch A, et al. Improving the hit-to-lead process: data-driven assessment of drug-like and lead-like screening hits. Drug Discov Today. 2006;11(3–4):175–180.
   PubMed Web of Science ®Google Scholar
• Davis AM, Teague SJ, Kleywegt GJ. Application and limitations of X-ray crystallographic data in structure-based ligand and drug design. Angew Chem Int Ed Engl. 2003;42(24):2718–2736.
   PubMed Web of Science ®Google Scholar
• Potamitis C, Zervou M, Katsiaras V, et al. Antihypertensive drug valsartan in solution and at the AT1 receptor: conformational analysis, dynamic NMR spectroscopy, in silico docking, and molecular dynamics simulations. J Chem Inf Model. 2009;49(3):726–739.
   PubMed Web of Science ®Google Scholar